Genomic aberrations in PCa do divide 74% of the disease into several groups, mostly based on presence of specific gene fusions (ERG, ETV1/4, and FLI1) and mutations (SPOP, FOXA1 and IDH1); however, PCa belongs overall to the low mutational burden class of tumors. The gene discussed is ERG; the disease is posterior cortical atrophy.